MedTrace Logo

Megestrol and Exercise in Treating Patients With Cancer-Related Weight Loss

NCT00004912 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2012-05-30

No results posted yet for this study

Summary

RATIONALE: Megestrol helps improve appetite. Exercise may decrease cancer-related fatigue, improve strength, and build up lost muscle tissue. Exercise plus megestrol may be effective treatment for cancer-related weight loss.

PURPOSE: Phase II trial to study the effectiveness of megestrol plus exercise to improve appetite, increase strength, gain lean body tissue, and decrease fatigue in patients who have cancer-related weight loss.

Conditions

  • Cachexia
  • Fatigue
  • Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG

megestrol acetate

PROCEDURE

physical therapy

Sponsors & Collaborators

Principal Investigators

  • Jamie Hayden Von Roenn, MD · Robert H. Lurie Cancer Center

Study Design

Purpose
SUPPORTIVE_CARE

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-01-31
Primary Completion
2003-11-30
Completion
2003-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00004912 on ClinicalTrials.gov